# HTLV-1 in Pregnancy and Neonatal Health: Evidence, Challenges, and Future Directions

## TL;DR

This paper reviews HTLV-1 transmission during pregnancy, focusing on diagnostic methods, vertical transmission risks, and the importance of prenatal screening to prevent neonatal complications.

## Contribution

The paper emphasizes the role of prenatal screening and breastfeeding cessation in reducing HTLV-1 transmission and highlights the psychosocial impact on infected mothers.

## Key findings

- Vertical transmission of HTLV-1 primarily occurs through breastfeeding.
- Prenatal screening programs in Japan and Brazil have reduced transmission rates.
- HTLV-1 infection may increase risks of preterm birth and low birth weight.

## Abstract

Human T-cell lymphotropic virus (HTLV), a retrovirus associated with severe conditions such as leukemia/lymphoma and myelopathy, exhibits variable global prevalence, with higher rates observed in regions such as northeastern Brazil and sub-Saharan Africa. While intrauterine transmission can occur via viral expression in placental tissue and contact with umbilical cord blood, the predominant route is vertical transmission through breastfeeding. Diagnostic testing, particularly serological screening with ELISA and confirmatory methods such as Western blot and PCR, is essential for early detection during pregnancy. The implementation of prenatal screening programs, as seen in Japan and Brazil, has proven effective in reducing vertical transmission by guiding interventions such as breastfeeding cessation in infected mothers. Beyond clinical implications, the psychosocial impact on affected pregnant women highlights the need for an interdisciplinary approach. Although the association between HTLV infection and adverse obstetric outcomes remains controversial, studies suggest increased risks of preterm birth, low birth weight, and other neonatal complications. Given the importance of early diagnosis and prevention, universal prenatal screening protocols represent a critical strategy to reduce viral transmission and its long-term consequences.